Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3712
AVXL
Anavex Life Sciences Corp. - Common Stock
1.51 USD+1.34%-9.04%-42.15%-82.40%139.97 M USD
3713
VYGR
Voyager Therapeutics, Inc. - Common Stock
2.27 USD-7.35%-7.72%-28.39%-51.18%139.87 M USD
3724
NERV
Minerva Neurosciences, Inc - Common Stock
2.89 USD-9.12%-14.50%-34.17%+19.92%137.99 M USD
3725
KRRO
Korro Bio, Inc. - Common Stock
9.37 USD-7.78%-8.14%-31.05%-75.91%137.98 M USD

Frequently asked questions about Innate Pharma S.A. ADS

What is the Innate Pharma S.A. ADS stock price today?

The current price of Innate Pharma S.A. ADS (IPHA) is 1.48. Over the past 24 hours, the stock has changed by -8.64%. Follow the IPHA chart for real-time price dynamics.

What is the stock ticker of Innate Pharma S.A. ADS?

Innate Pharma S.A. ADS trades under the ticker IPHA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Innate Pharma S.A. ADS stock going up?

IPHA has changed by -6.33% over the last week, -20.43% over the last month, and -31.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Innate Pharma S.A. ADS?

Innate Pharma S.A. ADS currently has a market capitalization of 138.7 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

How many employees does Innate Pharma S.A. ADS have?

As of the latest available data, Innate Pharma S.A. ADS has 163 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Innate Pharma S.A. ADS stock?

You can buy Innate Pharma S.A. ADS (IPHA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Innate Pharma S.A. ADS stock?

Investing in Innate Pharma S.A. ADS requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IPHA chart and related analysis on metatrader.com as part of your research.

News